National Institute on Aging invests an additional $7.3 million into NU-9
Funding will support research into the ALS drug’s effectiveness for other neurodegenerative diseases
With its ability to improve neuron health, experimental drug NU-9 has already shown promise in reversing amyotrophic lateral sclerosis (ALS). Now, the National Institute on Aging (NIA) …
Read More